Applicant, as named in the Orange Book
Medexus
Next listed expiry: Rasuvo on 1 Jun 2029. 2 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Rasuvo NDA 205776 · 9 strengths methotrexate | 1 Jun 2029 patent, carve-out possible |
| Grafapex NDA 214759 · 2 strengths treosulfan | 21 Jan 2032 exclusivity |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.